You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


Advertisement

ABOUT ARCHIVES
Advanced Search

Welcome   | My Account | E-mail Alerts | RSS | Access Rights | Sign In


  Vol. 150 No. 6, June 1990 TABLE OF CONTENTS
  Online Only
 •  Online First Table of
Contents
  ORIGINAL INVESTIGATIONS
 •Online Features
 This Article
 •References
 •Full text PDF
 • Reply to article
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citation map
 •Citing articles on HighWire
 •Citing articles on Web of Science (16)
 •Contact me when this article is cited
 Related Content
 •Similar articles in this journal
 Social Bookmarking
  Add to CiteULike Add to Connotea Add to Delicious Add to Digg Add to Facebook Add to Reddit Add to Technorati Add to Twitter What's this?

Does Multiple-Dose Charcoal Therapy Enhance Salicylate Excretion?

Lorrie A. Kirshenbaum, MSc; Susan C. Mathews, RN; Daniel S. Sitar, PhD; Milton Tenenbein, MD, FRCPC

Arch Intern Med. 1990;150(6):1281-1283.


Abstract



• Multiple-dose charcoal therapy has been shown to increase the excretion of some drugs. This study assesses the effects of this intervention on salicylate excretion in the postabsorptive phase. Ten human volunteers participated in this randomized, controlled, crossover, two-limbed protocol. On two occasions each volunteer ingested 2880 mg of aspirin. During the experimental limb, 25 g of activated charcoal was ingested at 4, 6, 8, and 10 hours after drug ingestion. Pharmacokinetic data were derived from serial serum salicylate concentrations, and urinary salicylate excretion was quantified. Treatment effects were 9% and 18%, respectively. Although both are significant, they are clinically modest, making multiple-dose charcoal therapy of questionable value for acute salicylate poisoning. Controlled data demonstrating the clinical efficacy of this therapy are required to validate it as an intervention for this condition.

(Arch Intern Med. 1990;150:1281-1283)



Author Affiliations



From the Departments of Pharmacology and Therapeutics (Mr Kirshenbaum and Drs Sitar and Tenenbein), Pediatrics and Child Health (Ms Mathews and Dr Tenenbein), and Medicine (Drs Sitar and Tenenbein), University of Manitoba; and the Manitoba Poison Control Centre (Dr Tenenbein), Winnipeg, Canada.


Footnotes



Accepted for publication December 1,1989.

Reprint requests to Children's Hospital, 840 Sherbrook St, Winnipeg, Manitoba, Canada R3A 1S1 (Dr Tenenbein).



Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Delicious Delicious   Add to Digg Digg   Add to Facebook Facebook   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter     What's this?

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Acute poisoning: understanding 90% of cases in a nutshell
Greene et al.
Postgrad. Med. J. 2005;81:204-216.
ABSTRACT | FULL TEXT  

Adult Toxicology in Critical Care: Part II: Specific Poisonings
Mokhlesi et al.
Chest 2003;123:897-922.
FULL TEXT  

An evidence based flowchart to guide the management of acute salicylate (aspirin) overdose
Dargan et al.
Emerg. Med. J. 2002;19:206-209.
ABSTRACT | FULL TEXT  

Multiple-Dose Charcoal and Whole-Bowel Irrigation Do Not Increase Clearance of Absorbed Salicylate
Mayer et al.
Arch Intern Med 1992;152:393-396.
ABSTRACT  





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | PHYSICIAN JOBS | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 1990 American Medical Association. All Rights Reserved.